UNII 3NXW29V3WO

HYPROMELLOSE, UNSPECIFIED

Unique Ingredient Identifier 3NXW29V3WO is listed as a unspecified ingredient
Unii3NXW29V3WO
Preferred Substance NameHYPROMELLOSE, UNSPECIFIED
Rn9004-65-3
NcitC80902
Rxcui27334
Inn Id2412
Unii TypeUNSPECIFIED INGREDIENT
RN9004-65-3
NCITC80902
RXCUI27334
INN ID2412
MFPolymer substance not supported

Alternate Names

Dosage Forms

UNII 3NXW29V3WO HYPROMELLOSE, UNSPECIFIED is commonly included in medications in the following forms.

RouteDosage FormPotency
ORALCAPSULE113.6577 MG
ORALTABLET21.8 mg
BUCCALTABLET24 MG
INHALATIONPOWDER45.67 MG
IRRIGATIONSOLUTION NA
NASALPOWDER, FOR INHALATION NA
NASALSOLUTION, SPRAY0.1 %
NASALSOLUTION, SPRAY, METERED, PUMP0.014 %
NASALSPRAY0.1 %
NASALSPRAY, METERED0.1 %
OPHTHALMICGEL2.25 %
OPHTHALMICSOLUTION0.5 %
OPHTHALMICSOLUTION, DROPS0.5 %
OPHTHALMICSOLUTION/DROPS0.5 %
OPHTHALMICSUSPENSION0.5 %
OPHTHALMICSUSPENSION, DROPS0.6 %
ORALCAPSULE155 MG
ORALCAPSULE, COATED PELLETS3.32 MG
ORALCAPSULE, DELAYED ACTION67.87 MG
ORALCAPSULE, DELAYED ACTION, COATED, HARD GELATIN20 MG
ORALCAPSULE, DELAYED ACTION, ENTERIC COATED NA
ORALCAPSULE, DELAYED RELEASE96 MG
ORALCAPSULE, ENTERIC COATED PELLETS64.43 MG
ORALCAPSULE, EXTENDED RELEASE118 MG
ORALCAPSULE, HARD GELATIN73.9 MG
ORALCAPSULE, SOFT GELATIN LIQUID-FILLED118 MG
ORALCAPSULE, SUSTAINED ACTION670.04 MG
ORALCONCENTRATE NA
ORALDROPS1.3 MG/1ML
ORALFILM, SOLUBLE33.5 MG
ORALGRANULE NA
ORALGRANULE, ENTERIC COATED17.2 MG
ORALGRANULE, FOR ORAL SUSPENSION10.6 MG
ORALPELLET6.7 MG
ORALPOWDER, FOR ORAL SUSPENSION75 MG/5ML
ORALPOWDER, FOR RECONSTITUTION150 MG/5ML
ORALPOWDER, FOR SUSPENSION65 MG/5ML
ORALSOLUTION4.5 MG/1ML
ORALSUSPENSION325 MG/5ML
ORALSUSPENSION, LIQUID5 MG/1ML
ORALSYRUP180 MG/5ML
ORALTABLET16.68 mg
ORALTABLET (IMMED./COMP. RELEASE), COATED19.2 MG
ORALTABLET (IMMED./COMP. RELEASE), FILM COATED24 MG
ORALTABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE10 MG
ORALTABLET, CHEWABLE22 MG
ORALTABLET, COATED245 MG
ORALTABLET, CONTROLLED RELEASE65.7 MG
ORALTABLET, DELAYED ACTION19.62 MG
ORALTABLET, DELAYED ACTION, ENTERIC COATED127.29 MG
ORALTABLET, DELAYED RELEASE16.4 MG
ORALTABLET, EXTENDED RELEASE450 MG
ORALTABLET, FILM COATED536.8 MG
ORALTABLET, FILM COATED, EXTENDED RELEASE48.01 MG
ORALTABLET, FOR SUSPENSION45 MG
ORALTABLET, MULTILAYER, EXTENDED RELEASE125.5 MG
ORALTABLET, ORALLY DISINTEGRATING18 MG
ORALTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE29 MG
ORALTABLET, SUSTAINED ACTION400 MG
ORALTABLET, SUSTAINED ACTION, COATED221 MG
ORALTABLET, SUSTAINED ACTION, FILM COATED58.33 MG
ORALTABLET, SUSTAINED RELEASE, FILM COATED300 MG
RECTALGEL8.7 %
TOPICALEMULSION, CREAM0.1 %W/W
TOPICALEMULSION, LOTION0.1 %W/W
TOPICALJELLY2.5 %W/W
TOPICALLOTION0.1 %W/W
TOPICALPATCH NA
TOPICALSOLUTION4 %W/V
TOPICALSOLUTION, DROPS0.11 %W/V
URETHRALJELLY2.3 %
VAGINALGEL3.5 %
VAGINALINSERT52.6 MG
VAGINALTABLET5 MG
VAGINALTABLET, FILM COATED54.21 MG
ORALTABLET, FILM COATED9.6 mg

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.